These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1561237)

  • 41. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
    Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP
    Invest New Drugs; 2015 Apr; 33(2):290-9. PubMed ID: 25563824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porphyrin photosensitivity in cell lines expressing a heat-resistant phenotype.
    Gomer CJ; Rucker N; Wong S
    Cancer Res; 1990 Sep; 50(17):5365-8. PubMed ID: 2143688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
    Boesch D; Muller K; Pourtier-Manzanedo A; Loor F
    Exp Cell Res; 1991 Sep; 196(1):26-32. PubMed ID: 1879470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
    Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN
    Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP; Brown GA; Goldenberg GJ
    Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
    Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a novel porphyrin-based photosensitizer on sensitive and multidrug-resistant human gastric cancer cell lines.
    Chen J; Mao L; Liu S; Liang Y; Wang S; Wang Y; Zhao Q; Zhang X; Che Y; Gao L; Liu T
    J Photochem Photobiol B; 2015 Oct; 151():186-93. PubMed ID: 26302181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of protein kinase beta isozyme in multidrug resistance in murine leukemia P388/ADR cells.
    Gollapudi S; Soni V; Thadepalli H; Gupta S
    J Chemother; 1995 Apr; 7(2):157-9. PubMed ID: 7666124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane.
    Hoke GD; McCabe FL; Faucette LF; Bartus JO; Sung CM; Jensen BD; Heys JR; Rush GF; Alberts DW; Johnson RK
    Mol Pharmacol; 1991 Jan; 39(1):90-7. PubMed ID: 1898982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A; Glaubiger D; Weintraub H
    Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
    Badiner GJ; Moy BC; Smith KS; Tarpley WG; Groppi VE; Bhuyan BK
    Br J Cancer; 1990 Sep; 62(3):378-84. PubMed ID: 2145026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
    Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
    Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.